Related Experiment Video
Updated: Aug 19, 2026
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells
A De Blasio1, C Messina, A Santulli
1Dipartimento di Biologia Cellulare e dello Sviluppo, Sezione di Biochimica, Università di Palermo, Policlinico, via del Vespro 129, 90127 Palermo, Italy.
Abstract:
This study describes the molecular mechanism by which treatment with 3-AB, a potent inhibitor of PARP, allows human osteosarcoma MG-63 cells to restrict growth and enter differentiation. Our findings show that in MG-63 cells, aberrant gene expression keeps Rb protein constitutively inactivated through hyperphosphorylation and this promotes uncontrolled proliferation of the cells. After 3-AB-treatment, the poly(ADP-ribosyl)ation of nuclear proteins markedly decreases and this results in an increase in both the hypophosphorylated active form of Rb and pRb/E2F complexes. These effects are accompanied by G1 arrest, downregulation of gene products required for proliferation (cyclin D1, beta-catenin, c-Jun, c-Myc and Id2) and upregulation of those implicated in the osteoblastic differentiation (p21/Waf1, osteopontin, osteocalcin, type I collagen, N-cadherins and alkaline phosphatase). Our study suggests that use of PARP inhibitors may induce a remodeling of chromatin with the reprogramming of gene expression and the activation of differentiation.
Insights
Poly(ADP-ribose) polymerase (PARP) inhibitors like 3-AB halt osteosarcoma cell growth. Treatment with 3-AB reactivates the Rb protein, promoting cell differentiation and altering gene expression for osteoblastic development.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Osteosarcoma MG-63 cells exhibit uncontrolled proliferation due to hyperphosphorylated, inactivated Rb protein.
- Aberrant gene expression contributes to the aggressive proliferation characteristic of osteosarcoma.
Purpose of the Study:
- To elucidate the molecular mechanism by which 3-AB, a PARP inhibitor, induces growth restriction and differentiation in human osteosarcoma MG-63 cells.
- To investigate the role of poly(ADP-ribosyl)ation and Rb protein activity in osteosarcoma cell fate.
Main Methods:
- Treatment of MG-63 cells with 3-AB, a potent PARP inhibitor.
- Analysis of Rb protein phosphorylation status and pRb/E2F complex formation.
- Assessment of gene expression profiles related to cell proliferation and osteoblastic differentiation.
Main Results:
- 3-AB treatment significantly decreased poly(ADP-ribosyl)ation of nuclear proteins.
- This led to increased hypophosphorylated, active Rb protein and enhanced pRb/E2F complex formation.
- Cell cycle arrest at G1 phase was observed, along with downregulation of proliferation markers and upregulation of osteoblastic differentiation markers.
Conclusions:
- PARP inhibition by 3-AB can reprogram gene expression and activate osteoblastic differentiation in osteosarcoma cells.
- PARP inhibitors may induce chromatin remodeling, offering a potential therapeutic strategy for osteosarcoma.
Related Concept Videos
02:23Abnormal Proliferation
01:31The Intrinsic Apoptotic Pathway
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...